Introduction
C-Abl plays an important role in many aspects of cell growth and dierentiation. It is unusual in that it is present in both nucleus and cytoplasm (Taagepera et al., 1998) . It contains several important binding domains, which include the tyrosine kinase domain, an SH2 domain capable of binding to phosphotyrosine residues, an SH3 domain that binds proline-rich regions and for nuclear localization, F-and G-actin binding domains and others (Wang, 1993; Van Etten, 1999) . In the nucleus, c-Abl can bind to DNA, and to the transcription factor Elf-1. It can phosphorylate RNA polymerase II (Kipreos and Wang, 1992; Welch and Wang, 1993; Baskaran et al., 1993) and c-Jun (Barila et al., 2000) . It binds to retinoblastoma protein (Rb) in a cell-cycle dependent manner (Welch and Wang, 1993) . Its over-expression is reported to lead to growth arrest (Sawyers et al., 1994; Wen et al., 1996) . DNA damage induced by irradiation induces the expression of ATM, a serine/threonine kinase that is mutated in ataxia telangiectasia, which in turn activates c-Abl (Baskaran et al., 1997; Shafman et al., 1997) . Such activation leads to growth arrest and may be mediated through a unique p53-mediated signal transduction pathway (Wen et al., 1996) .
One of the explanations for these diverse biological properties of c-Abl could be due to the existence of multiple isoforms of c-Abl; the biological functions of each of these isoforms are unclear (Ben-Neriah et al., 1986) . Analysis of c-abl transgenic knockout mice rescued with dierent c-abl isoforms suggests that no major dierences exist between the two major isoforms, i.e., Type I c-abl and Type IV c-abl (Hardin et al., 1996) . However, dierences in lymphoid cell defect were noted, and the best complementation group was observed in mice rescued by both Type I and Type IV c-abl. Dierent c-Abl isoforms may indeed have dierent biological functions. Daniel et al. (1996 Daniel et al. ( , 1998 have shown that Type I c-Abl is necessary for LPS (lipopolysaccharide)-induced dierentiation and Type IV c-Abl is inhibitory to apoptosis. Likewise, lymphoid cells of c-abl-de®cient mice or cells with reduce c-Abl show increased sensitivity to apoptosis (Dorsch and Go, 1996; Daniel et al., 1998; Le et al., 1998) .
By means of a functional expression cloning strategy, we have previously established that Ran GTPase (same as Lps/Ran or Ran-Lps) is important in LPS-induced polyclonal B cell activation (Kang et al., 1996) and in LPS-induced activation of macrophages (Le et al., 1998) . Over-expression of one cDNA clone, RanC/d in macrophages leads to down-regulation of TNFa production in vitro and to endotoxin resistance in vivo (Yuan et al., 2000; Zhao et al., 2001; Wong et al., 2000a,b) . In this study, we show that Type I c-Abl physically and speci®cally associates with Ran. This association appears to be LPS dose dependent. Formation of this complex is detectable in LPSstimulated B cells from LPS-responder mice but absent in endotoxin-resistant C3H/HeJ inbred mice.
Results

Involvement of c-Abl and Ran in LPS-mediated differentiation
To examine if Type I c-abl and Ran are involved in LPS signal transduction, we treated 70Z/3 lymphoid cells with a number of speci®c ODNs (oligonucleotides), with or without 5 mg/ml of LPS stimulation, and recorded the number of cells in each culture 48 h later. No signi®cant dierence was observed in cultures treated with Type I c-abl or Ran sense, nonsense, scrambled ODNs, but a twofold release of blockage in proliferation was observed with antisense Type I c-abl or Ran ODNs treatment (Figure 1a ). This release was also present in same cultures stimulated with 100 mg/ml of LPS, but it was absent in cultures containing antisense Type IV c-abl ODNs or its control ODNs used in our previous study (Daniel et al., 1996) .
To assess if the increase in proliferation was inversely correlated with decrease in dierentiation, we examined the production of immunoglobulin by these cultures. To visualize immunoglobulin production, immunoblots of cells from these cultures were hybridized with goat-antimouse IgG (BRL) as described before (Daniel et al., 1996) . Figure 1b shows that, in the absence of LPS stimulation, no signi®cant amount of IgG was produced, whereas in the presence of LPS stimulation, a signi®cant amount of IgG was produced in cultures treated with the sense ODNs against type I c-Abl or Ran. But in cultures treated with either antisense against Type I c-Abl or Ran, IgG production became undetectable. Taken together, the results from Figure 1 suggest that both Type I c-Abl and Ran are involved in LPS signal transduction pathway.
We next asked if Type I c-Abl might have a physical relationship with Ran. We performed immunoprecipi- /ml were plated into 24-well plate, with or without 5 mg/ml LPS, and with or without 10 mM ODNs speci®c for Type I c-Abl or Ran for 48 h. Triplicate wells were prepared for each experimental point. Cell counts from each culture were recorded at the end of the culture. (b) Immunoglobulin synthesis after LPS stimulation and antisense treatment. Twenty-four hours after LPS or antisense treatment, 70Z/3 lymphoid cells were harvested and lysed. Whole cell lysates were resolved by SDS ± PAGE, blotted onto ®lter, and the ®lter hybridized with goat anti-mouse IgG as described (Daniel et al., 1995) . H=immunoglobulin heavy chain; L=immunoglobulin light chain; S=sense ODN; AS=antisense ODN tation/Western blot analysis on lysates of LPSstimulated or non-stimulated cells, where anti-Ran was the precipitating antibody and monoclonal 8E9 anti-Abl was the blotting antibody. While the total amount of proteins in each lane was similar, a signi®cant amount of c-Abl was present in Ran immunoprecipitates of LPS-stimulated cells but not in non-stimulated cells, and the amount of this complex increased with the dose of LPS stimulation (Figure 2 ). Such complex was not observed when a non-speci®c rat IgG isotype antibody was used in place of 8E9 as the blotting antibody. Also, this complex could be observed in lysate containing as much as 1% Triton X, suggesting that the association of these molecules are relatively tight.
Specific association of Type I c-Abl with Ran-Lps
We previously showed that both Type I c-Abl and Ran are involved in LPS-mediated dierentiation (Daniel et al., 1996; Kang et al., 1996) . Therefore, we proceeded to examine if Type I c-Abl and Ran have a physical association, and if so, whether the binding is speci®c. We performed IP/Western on lysates of LPS-stimulated 70Z/3 cells treated with type I c-abl or type IV c-abl sense or antisense ODNs, using anti-Ran as the IP antibody and 8E9 anti-Abl as the blotting antibody. We observed that while the Abl/ Ran complex was present in cells treated with all control ODNs, it was absent in cells treated with Type I c-abl antisense ODN, con®rming and extending our previous contention that Type I c-Abl is involved in LPS signaling (Figure 3a ). Because the complex was still present in LPS-stimulated cells treated with antiType IV c-abl ODNs, the involvement of c-Abl appears to be speci®c to Type I isoform, as the two isoforms dier from each other only by 30 amino acid residues at the amino-terminal end. To further con®rm this result, we took a direct approach by tagging Type I and Type IV c-abl cDNAs with a T7-epitope sequence such that expression of each of these constructs would produce a fused Type I c-Abl-T7 or Type IV c-Abl-T7 protein detectable by an anti-T7 monoclonal antibody (Figure 3b) . Accordingly, the expression plasmids were separately introduced into 70Z/3 B lymphoid cells and the corresponding positively transfected cells were analysed, before and after LPS stimulation. We performed various IP/ Western blots on lysates of these cells using anti-Ran as the precipitating antibody, and anti-T7 antibody as the blotting antibody. While the cells expressing Type I c-Abl-T7 showed the presence of the c-Abl band only after LPS stimulation, the cells expressing Type IV c-Abl-T7 did not (Figure 3c ). Immunoblots with anti-T7 or 8E9 anti-Abl antibody without prior immunoprecipitation with anti-Ran showed that cAbl and T7-epitope tagged c-Abl were present in all samples (lower panels of Figure 3c ). These data strengthen the speci®c nature of such association because c-Abl is a very large protein, with a molecular weight of 140 kD, but the two c-Abl isoforms diers from each other by only about 20 ± 30 amino acid residues at the 5' terminus of the protein. Furthermore, we also observed that Type IV c-Abl speci®cally associates with p53 instead of, as Type I c-Abl, with Ran (not shown). Therefore, Type I c-Abl appears to interact with Ran speci®cally in B cells upon LPS stimulation.
Increased Type I c-Abl tyrosine kinase activity after LPS stimulation
To investigate the biochemical consequence of the Abl/ Ran complex, we asked whether LPS stimulation could enhance c-Abl tyrosine kinase activity. The results show that c-Abl kinase activity increased with the amount of LPS added to the culture, while the level of c-Abl remained relatively constant (Figure 4a ). To examine whether this increase was mainly due to Type I c-Abl tyrosine kinase activity, we treated the cells with Type I c-abl or Type IV c-abl antisense or sense ODNs. Both antisense ODNs were shown to reduce the level of c-Abl protein (Daniel et al., 1996) . In the presence of LPS, Type I c-abl antisense ODN treatment abrogated the increased tyrosine kinase activity, whereas the sense-ODN treatment did not, and this increase was present in cells with Type IV cabl antisense ODN treatment (Figure 4b ). These data suggest that LPS stimulated the increase of Type I cAbl tyrosine kinase activity but not that of Type IV cAbl. Treatment with Type IV c-abl antisense ODN, however, eliminated the basal c-Abl kinase activity in non-stimulated cells (Figure 4b ).
Because Ran associates with Type I c-Abl, we next asked whether reduction of Ran would likewise reduce c-Abl kinase activity in LPS-stimulated cells (Type I activity) but not in non-stimulated cells (Type IV activity). This is indeed true (Figure 5a ). There was no reduction of this tyrosine kinase activity in cells treated with the sense, nonsense or scrambled ODN sequences (Figure 5a,b) . Thus the level of Ran correlated with Type I c-Abl kinase activity. Consistently, overexpression of Ran after retroviral gene transfer resulted in enhancement of c-Abl kinase activity in LPSstimulated cells as compared to cells transduced with the N2 parental vector or to non-stimulated cells (not shown). This kinase activity was attributed to that of Type I c-Abl, as 70Z/3 cells treated with Ran antisense ODN did not aect the basal c-Abl kinase activity (Type IV, Figure 4b ) in non-stimulated cells ( Figure  5c ). Thus, Type I c-Abl tyrosine kinase activity is Ran dependent, whereas Type IV c-Abl kinase activity is not, and it accounts for the basal c-Abl activity in nonstimulated cells. As complex formation appears to be LPS dose dependent (Figure 2) , it may have a physiological relevance. To examine this possibility, we asked whether the complex might be present in B cells of endotoxin sensitive inbred mice and absent in endotoxin-resistant C3H/HeJ mice. Ten million primary B cells were stimulated with 5 mg/ml LPS for 24 h. The cells were then harvested, lysed and then subjected to IP/Western blot analysis. The results showed that in primary B cells of endotoxin-sensitive C3H/HeOuJ cells, LPS stimulated the association of Type I c-Abl and Ran, whereas in B cells of endotoxinresistant C3H/HeJ mice, LPS did not stimulate such association (Figure 6 ). These data strongly suggest the physiological signi®cance of the speci®c association between Type I c-Abl and Ran, which is a function of LPS stimulation.
Discussion
In this study, we showed that Type I c-Abl isoform associates with Ran, and this association appears to be dependent on the dose of LPS stimulation. This ®nding con®rms and extends our previous reports, where we showed that Type I c-Abl and Ran are involved in LPS stimulation (Daniel et al., 1996; Kang et al., 1996; Le et al., 1998; Wong et al., 1999; Yuan et al., 2000; Zhao et al., 2001) . Formation of this (Figure 3 ). This speci®city is particularly appreciated when one considers the fact that c-Abl is a very large protein, with a molecular weight of 145 kD, and yet Type I diers from Type IV only by 30 amino acid residues at the amino terminus of the protein. These observations also highlight the importance of the ®rst variable exons of c-abl, which de®ne the amino termini of various c-Abl isoforms. Our results suggest the presence within this variable exon of Type I c-abl of an unknown binding motif to which Ran or other molecules may interact to produce an LPS-induced signal transduction. Consistent with this idea is our preliminary data showing that Type IV c-Abl binds to p53 and another molecule (not shown), unlike Type I c-Abl, which associates with Ran instead.
We and others have reported that c-Abl is involved in LPS-induced proliferation and dierentiation Hardin et al., 1996; Le et al., 1998) , and the involvement of tyrosine kinase in LPSinduced responses has been suggested frequently (Dong et al, 1993a,b; Novogrodsky et al., 1994; Orlicek et al., 1996) . In this report, that Type I cAbl speci®cally associates with Ran is in keeping with the above publications and our recent reports that Ran is also an LPS response gene (Kang et al., 1996; Wong et al., 1999; Zhao et al., 2001) . Ran GTPase normally exists in two forms within a cell, i.e., Ran/ GTP and Ran/GDP. Ran/GTP is bound by its exchange factors, one of which is RCC1 in mammalian cells, and the complex is present in the nucleus, and Ran/GDP associates with its GTPase-activating protein, Ran-GAP, which is largely cytoplasmic (Bischo et al., 1995; Koepp and Silver, 1996; Moore, 1996) . Ran has been reported to play important roles in many aspects of cell growth and development; including cell cycle control, nuclear transport of macromolecules, chromatin reorganization and mitotic spindle formation (Koepp and Silver, 1996; Goldfarb, 1997; Moore, 1996; Ohba et al., 1999; Wilde and Zheng, 1999) . These properties can certainly be related to LPS-induced B cell polyclonal activation, proliferation and blastogenesis, or LPS-induced macrophage activation. In parallel, c-Abl also translocates in and out of the nucleus, albeit the intracellular distribution of each c-Abl isoform is unknown (Taagepera et al., 1998) . Research in our laboratory along this direction is in further progress.
The association between c-Abl and Ran may be direct or indirect. C-Abl may be an eector that binds to an adaptor molecule such as the exchange factor or Ran-GAP. Adaptor molecules such as Grb2, Crk1 and Nck have been shown to interact with c-Abl, via the SH3 domain (Feller et al., 1994; Ren et al., 1994) . This type of interaction could result in enhanced kinase activity of Type I c-Abl as a result of their physical interaction induced by LPS (Figure 4) . On the other hand, the speci®c association between type I c-Abl and Ran may simply de®ne a speci®c set of molecules, which are dierent from those with type IV c-Abl, that are activated after LPS stimulation. Regardless which possibility is correct, both Ran and type I c-Abl are important intermediates in LPS-induced signal transduction.
By functional cDNA expression analyses, we have shown that a single point mutation at the 3'-UTR of Ran cDNA is important in mediating LPS biological responses. We made that conclusion based on results of various comparative functional analyses employing two cDNAs, RanT/n and RanC/d. These two cDNAs are identical except at position 870, where a thymidine is present in RanT/n, and a cytidine in RanC/d (Wong et al., 1999) . The Ran protein expressed by either cDNA is identical, and the amount and stability of both mRNAs are very similar (Chen et al., 2001, submitted) . However, the amount of Ran protein expressed and accumulated by each of these two cDNAs is very dierent at steady state. In RanC/d cDNA transduced cells, a 10-fold higher amount of exogenous Ran protein was detected when compared to that in RanT/n transduced cells (Yuan et al., 2000; Zhao et al., 2001) . The nuclear accumulation rate of Ran from the two cDNAs is very dierent (Wong et al., 2001, submitted) . As predicted by computer modeling, and con®rmed by RNase T1 analysis, the secondary and tertiary structure of the two mRNAs may be very dierent. This could result in dierent intra-cellular localization of the two mRNAs, which is consistent with recent ®ndings of highly unconserved`zip-code' motifs that are frequently present in the 3-UTR of several mRNA species (Belasco and Brawerman, 1993; Chan and Struhl, 1997; Dubnau and Struhl, 1996; Evans et al., 1994; Kislauskis et al., 1993; Klausner et al., 1993; Ostareck-Lederer et al., 1994; Rivera-Pomar et al., 1996; Shaw and Kamen, 1986; Wilson and Treisman, 1988; Hel et al., 1996 Hel et al., , 1998 . According to this hypothesis, not only the amount of protein synthesized could be dierent, the protein may have dierential susceptibility to intracellular proteases. In this regard, several cytoplasmic proteases have been reported that degrade intermediates involved in LPS signal transduction.
The two dierent levels of Ran accumulated in dierent tissues or cells may also mediate dierent biological signals or same signal with dierent potency. In this regard, over expression of RanT/n cDNA in hyporesponsive B cells leads to partial restoration in LPS response, whereas over expression of the same cDNA in hyporesponsive macrophages results in no restoration, despite similar amount of the Ran protein derived from the transduced genes in both cells (Kang et al., 1996; Yuan et al., 2000; Zhao et al., 2001, and unpublished results) . Thus, more than one Ran mediated LPS signaling pathway may be operative in parallel with or independent from one another in a tissue speci®c manner. Elucidation of the mechanism(s) of tissue-speci®c regulations might provide insightful information regarding speci®c molecular targets bene®cial for therapeutic considerations.
Materials and methods
Treatment with antisense oligonucleotides (ODNs)
70Z/3 pre-B lymphoid cells were routinely grown and maintained in RPMI+10% Fetal calf serum +50 mM 2-mercaptoethanol, with or without 5 mg/ml of LPS stimulation, as described previously (Daniel et al., 1996) . The LPS was prepared and puri®ed by the method of Westphal waterphenol extraction as described (Sultzer, 1972) . For the experiments, they were treated with various ODNs for 24 h as described (Daniel et al., 1996) , the c-abl ODNs target codons 2 ± 7 of c-abl mRNAs. All ODNs were used at a ®nal concentration of 10 mM. Various ODNs for c-abl isoforms used in this study have been described (Daniel et al., 1996) . Ran antisense ODN is 5'-CAGGTCATCATCCTCATC-3' (codons 211 ± 216 of Ran unique 3'-terminus); Ran sense ODN is 5'-GATGAGGATGATGACCTG-3'. Ran scramble sequence (R1) is 5'-CTACGCGCTTCCAATTCC-3', (R2) is 5'-GACCTGCTACTACTCCTA-3', (N) is 5'-CTACTCC-TACTACTGGAC-3'.
Proliferation studies
To evaluate the eect of ODNs on growth of 70Z/3 cells, 1.5610 6 cells were plated in 1 ml of medium in each well of a 24-well plate. ODNs were added at a concentration of 10 mM. Twentyfour hours later, cell counts in triplicate wells were recorded.
Immunoprecipitation/Western blot analysis 70Z/3 pre-B lymphoid cells were plated into 25 cm 3¯a sks at 1610 6 cells/ml, with or without stimulation with various concentrations of LPS for 24 ± 48 h. The cells were then recounted and 10 7 viable cells per sample lysed in a lysis buer (10 mM Tris pH 7.6, 5 mM EDTA, 130 mM NaCl, 0.2% Triton X-100 and protease inhibitors). The lysates were then immunoprecipitated with anti-Abl antibody (8E9, 10 mg/ ml) or anti-Ran antibody (2 mg/ml, kind gift of Dr Mary Moore). The immunoprecipitates were resolved on 7% SDS ± PAGE, transferred to PVDF membrane and blotted with anti-Abl antibody (8E9). In some experiments, the cultures were treated with ODNs at concentration of 10 mM for 24 h prior to IP/Western analysis; LPS was also added to a ®nal concentration of 5 mg/ml, unless otherwise stated.
Western blot analysis
To detect immunoglobulin production by dierentiating 70Z/ 3 cells, 2610 6 cells per sample were lysed in the lysis buer containing 10 mM Tris.HCl (pH 8.0), 50 mM NaCl, 1% Triton X-100, 1 mM EDTA and protease inhibitors (aprotinin, AEBSF and leupeptin). The lysates were then pre-cleared by centrifugation; equal volume of sample buer (100 mM Tris.Cl pH 6.8, 2% glycerol, 0.02% bromphenol blue, 2% SDS and 2% mercaptoethanol) was added. The samples were then boiled and resolved on 12% SDS ± PAGE gel. Proteins were then transferred from gel to Immobilon-P membrane and blotted with goat anti-mouse IgG (GIBCO/BRL), which could detect all IgG subclasses. The immunoglobulin bands were then visualized on X-ray ®lm using the PhotoBlot chemiluminescent system (GIBCO/BRL), following supplier's recommended procedures.
Kinase assays
10
7 cells per sample were lysed in a lysis buer containing 10 mM TrisCl pH 7.6, 5 mM EDTA, 130 mM NaCl, 1% Triton X-100 and protease inhibitors (aprotinin, leupeptin, AEBSF). Immunoprecipitation was carried out using either 8E9 anti-Abl antibody (9,12) or polyclonal anti-Ran antibody (a gift from Dr Mary Moore, Baylor College). Protein G+ agarose (BMB) was used to pull down the protein-antibody complexes. The kinase assay was performed in 50 mM Tris pH 7.5, 10 mM MgCl 2 , 1 mM DTT, 20 mCi [g-32 P]ATP and protease inhibitors, at 308C, for 30 min. For LPS stimulation, 70Z/3 cells were plated onto 25 cm 3¯a sks at 1610 6 cells/ml and stimulated with various concentrations of LPS for 48 h. The cells were then recounted, and 10 7 viable cells per sample lysed in the lysis buer and immunoprecipitated as above.
Construction and expression of T7-tagged-type I c-abl and T7-tagged-type IV c-abl expression vectors
To insert the T7-epitope into c-abl sequence, we synthesized two complementary primers; each ends with a SalI overhang sequence. The primer sequences were: 5'-TCGA CA ATG GCT AGC ATG ACT GGT GGA CAG CAA ATG GGT CGG-3', and 5'-TCGA CCG ACC CAT TTG CTG TCC ACC AGT CAT GCT AGC CAT TG-3'. After synthesis, the primers were annealed, and ligated with SalI-digested type IV c-abl vector kindly provided by Dr Jean YJ Wang at UCSD. The 4.4 kb EcoRI ± HindIII type IV c-abl were then cloned into pMV-7 retroviral vector containing a TK-driven neo r gene at the 3' end of the retroviral genome. To generate type I c-abl construct, we performed RT ± PCR cloning on mRNA from 70Z/3 cells by synthesizing two primers speci®c for type I c-abl isoform sequence, with an EcoRI site located at the 5' end and a PstI site at the 3' end. The latter is an endogenous PstI site of type I c-abl isoform sequence. After RT ± PCR cloning, the 83 bp type I c-abl sequence was con®rmed by DNA sequence, which is identical to those reported by BenNeriah et al. (1986) . The whole sequence is as follows: 5'-CGA ATT [c-abl sequence follows] CCG [EcoRI sequence underlined] TTG GAG ATC TGT TTG AAG TTG GTG GGC TGC AAA TCC AAG AAG GGG CTC TCT TCG TCC TCC AGC TGC TAC CTG GAA GAA GCC CTG CAG [endogenous PstI site underlined] -3'. After construction and virus production, the c-abl isoform genes were then introduced into 70Z/3 cells and positive clones selected as we previously described (Daniel et al., 1995) . For LPS stimulation, 5 mg/ml of LPS were added to each culture and incubated for 24 h. The cells were then lysed and analysed as described above for immunoprecipitation and Western blots. Mouse anti-T7 monoclonal antibody was purchased from Novagen, and the amount and concentration used in this study was based on recommendations from the manufacturer.
